Fact Checked

SurvivorNet Fact Checking and Medical Review Standards:  

The SurvivorNet News Team creates high quality medical information that complies with our industry leading standards for factual accuracy and sourcing from leading experts at academic medical institutions. Every news article is thoroughly fact-checked by our physician collaborators. We vet each piece of work for factual integrity, impartiality, and clearly label any professional conflicts.

All SurvivorNet articles adhere to the following standards:

  1. All studies and research papers cited are from reputable academic medical institutions or peer-reviewed journals.
  2. When we use data, statistics, or quotes these references link to the original source.
  3. All content related to new treatments, drugs, procedures, and so on must clearly describe availability, side effects, treatment target (such as triple negative breast cancer)
  4. All medical information on SurvivorNet is sourced from respected medical professionals with verified medical credentials and links are provided to these sources.
  5. We strive to give the reader relevant background information and include, clearly-sourced contextual health information in all articles. Readers are clearly alerted to any conflicts of interest from a medical source or the authors of a cited study.
/ Updated June 29th, 2018

When Should I Consider Clinical Trials?

NOW
PLAYING
What Is the Role of Clinical Trials in Bladder Cancer?
NOW
PLAYING
What Can Genetics Tell Us About the Molecular Features of a Bladder Cancer Tumor?
NOW
PLAYING
How Should My Doctor and I Make a Treatment Plan For Bladder Cancer?
NOW
PLAYING
Immunotherapy Saved Lung Cancer Survivor Oswald Peterson
NOW
PLAYING
Comedian Kathy Griffin Embraces the Bumps Along the Road to Recovery After Surgery for Her Lung Cancer
NOW
PLAYING
Minnesota Senator Amy Klobuchar Reveals She Was Diagnosed With Breast Cancer, Treatment ‘Went Well’
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.